Wapnick Pamela

CIK 00019956571 companyEMERYVILLE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001995657

Recent Transactions

16 trades

Sale
Metagenomi Therapeutics, Inc.$MGX
Common Stock
2026-09-08$1.16/sh−1,911→ 206,580 total
Sale
Metagenomi Therapeutics, Inc.$MGX
Common Stock
2026-06-05$1.30/sh−2,884→ 208,491 total
Award
Metagenomi Therapeutics, Inc.$MGX
Common Stock
2026-04-01+24,000→ 211,375 total
Award
Metagenomi Therapeutics, Inc.$MGX
Stock Option (Right to Buy)
2026-04-01+144,000→ 144,000 total
Sale
Metagenomi Therapeutics, Inc.$MGX
Common Stock
2026-03-05$1.60/sh−1,581→ 187,375 total
Sale
Metagenomi Therapeutics, Inc.$MGX
Common Stock
2025-12-05$1.77/sh−1,576→ 188,956 total
Award
Metagenomi Therapeutics, Inc.$MGX
Common Stock
2025-12-01$1.60/sh+120,000→ 190,532 total
Sale
Metagenomi Therapeutics, Inc.$MGX
Common Stock
2025-09-05$1.81/sh−1,576→ 70,532 total
Sale
Metagenomi Therapeutics, Inc.$MGX
Common Stock
2025-06-06$1.75/sh−1,576→ 72,108 total
Award
Metagenomi Therapeutics, Inc.$MGX
Stock Option (Right to Buy)
2025-04-01+84,000→ 84,000 total
Award
Metagenomi Therapeutics, Inc.$MGX
Common Stock
2025-04-01+14,000→ 73,684 total
Sale
Metagenomi Therapeutics, Inc.$MGX
Common Stock
2025-03-05$1.87/sh−1,808→ 59,684 total
Sale
Metagenomi Therapeutics, Inc.$MGX
Common Stock
2024-12-05$1.86/sh−1,559→ 61,492 total
Sale
Metagenomi Therapeutics, Inc.$MGX
Common Stock
2024-09-05$2.88/sh−6,265→ 63,051 total
Award
Metagenomi Therapeutics, Inc.$MGX
Common Stock
2024-04-01+69,316→ 69,316 total
Award
Metagenomi Therapeutics, Inc.$MGX
Stock Option (Right to Buy)
2024-04-01+291,450→ 291,450 total

Companies

Metagenomi Therapeutics, Inc.
Chief Financial Officer
$MGX

Recent Filings

Address

C/O METAGENOMI THERAPEUTICS, INC. 5959 HORTON STREET, 7TH FLOOR

EMERYVILLE, CA, 94608

View on SEC.gov